Propanc Biopharma Inc
PPCB
NASDAQ
Biotechnology
$1.22
USD
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.27M
Volume 39.4K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 4.6 | 3.6 | 6.2 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 4.7 | 3.7 | 6.4 |
Operating Income | -4.7 | -3.7 | -6.4 |
EBITDA | -4.7 | -3.7 | -6.4 |
Other Income / Expense | 0.1 | 0.6 | 0.1 |
Total Other Income / Expense | -0.2 | 0.6 | 0.0 |
Income Before Income Taxes | -4.8 | -3.1 | -6.4 |
Income Taxes | 0.0 | 0.0 | 0.0 |
Net Income | -4.8 | -3.1 | -6.4 |
Consolidated Net Income / Loss | -4.8 | -3.1 | -6.4 |
Net Income Attributable to Common Shareholders | -4.8 | -4.0 | -6.4 |
Basic EPS | -$9.75 | -$7.50 | -$0.28 |
Diluted EPS | -$9.75 | -$7.50 | -$0.28 |
Basic Shares Outstanding | 0.5M | 0.5M | 22.4M |
Diluted Shares Outstanding | 0.5M | 0.5M | 22.4M |